CN1769482A - Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit - Google Patents

Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit Download PDF

Info

Publication number
CN1769482A
CN1769482A CN 200410065300 CN200410065300A CN1769482A CN 1769482 A CN1769482 A CN 1769482A CN 200410065300 CN200410065300 CN 200410065300 CN 200410065300 A CN200410065300 A CN 200410065300A CN 1769482 A CN1769482 A CN 1769482A
Authority
CN
China
Prior art keywords
adenosine
adenosine deaminase
reagent
acid
coenzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410065300
Other languages
Chinese (zh)
Inventor
王尔中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410065300 priority Critical patent/CN1769482A/en
Publication of CN1769482A publication Critical patent/CN1769482A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for determining the activity of adenosine deaminase, and also the reagent kit for adenosine deaminase diagnosis. The reagent kit comprises cushioning solution, adenosine, 2-ketoglutaric ester, deacidized type coenzyme, adenosine triphosphate, phosphoenolpyruvate phosphatase, glutamate dehydrogenase, glutamic kinase, pyruvate kinase, lactate dehydrogenase, and stabilizer. By mixing sample and reagent of a predetermiend volumetric ratio, generating coupling reaction between them, subjecting the final reactant to biochemiscal analyser, the main wavelength absorbancy variance ratio (speed) can be detected, and the activity of the adenosine deaminase can thus be measured. The method of the invention can be used to obtain the needed measurement result purely through biochemical analytic instruments, and advantages of the method include higher sensibility, better accuracy, less susceptibility to contamination of internal or external materials, and easy application.

Description

Adenosine deaminase activity determination method and adenosine deaminase diagnosis reagent kit
Technical field
The present invention relates to a kind of method of measuring activity of adenosine deaminase, the invention still further relates to simultaneously, belong to medical test determination techniques field in order to realize the adenosine deaminase diagnosis reagent kit of this method.
Background technology
Medical research shows, adenosine deaminase is the nucleic acid metabolism enzyme that a kind of and body cell immunocompetence have important relationship.Therefore, the mensuration of activity of adenosine deaminase is used as good pernicious ascites pleural fluid, cerebrospinal fluid differential diagnosis, severe combined immunodeficiency disease (SCID), acute and chronic hepatitis, liver cirrhosis, the important diagnostic sign that diseases such as liver cancer are differentiated.
The activity determination method of adenosine deaminase mainly contains active nucleus method, physical method and biochemical process.Understand according to the applicant, generally adopt the UV-light method at present in the world, its measuring principle is: adenosine (white crystalline powder)+water (H2O) Adenosine deaminaseInosine (Inosine)+ammonium ion (NH4+), the inosine that this reflection process generates can be that the 265nm place manifests at wavelength, therefore can pass through the size of the big or small directly reflection activity of adenosine deaminase of this wavelength place absorbancy of mensuration.Yet this method can't be measured with the visible light analysis instrument of general hospital, and needs to use special ultraviolet light analyzer, therefore is difficult to apply conscientiously.
Retrieval finds, application number is 03128092.7, the applying date is that the Chinese patent application that 2003.05.29, name are called " a kind of reagent and method for making thereof of measuring adenosine deaminase " discloses the mensuration reagent of using the preparation of enzyme reaction product oxidized form nicotinoyl ammonia coenzyme.The enzymic measuring reagent of this invention indication does not add assaying reaction required reduced form nicotinoyl ammonia coenzyme or its analogue, and add its reaction product oxidized form nicotinoyl ammonia coenzyme or its analogue, and generate required enzyme of reduced coenzyme and substrate system accordingly, by in reagent, forming long response time systems such as enzyme-substrate-NAD or enzyme-substrate-NADP, this class oxidized coenzyme or the slow circulation of its analogue are reduced to reduced form nicotinoyl ammonia coenzyme or its analogue, when the reduced form nicotinoyl ammonia coenzyme that is reduced or its analogue reached certain concentration, the enzyme process reagent of this invention indication just can reach the purpose of measuring adenosine deaminase in the sample and isozymes activity thereof.This characteristic feature of an invention is to provide an endogenous synthesizing adenosine desaminase to react the adenosine deaminase reagent of needed reduced form nicotinoyl ammonia coenzyme for the test of adenosine deaminase.One of its shortcoming is, this system is in the needed reduced form nicotinoyl of formation reaction ammonia coenzyme, also offset the activity of part adenosine deaminase reagent (reaction of adenosine deaminase coupling glutamate dehydrogenase must be oxidized to reduced form nicotinoyl ammonia coenzyme oxidized form nicotinoyl ammonia coenzyme), caused the accuracy of reagent test to reduce greatly.Two of its shortcoming is that this reagent must react for some time before official testing in advance, so that can produce enough reduced form nicotinoyl ammonia coenzyme, has so just caused the result that slow action cannot save a critical situation, brings very big inconvenience to test.
Summary of the invention
The technical problem to be solved in the present invention is: propose a kind of measuring method that can overcome the activity of adenosine deaminase of above prior art shortcoming, provide simultaneously in order to realize the adenosine deaminase diagnosis reagent kit of this method.Adopt the reagent in this test kit not only can on ultraviolet analyser or half, automatic clinical chemistry analyzer, carry out adenosine deaminase activity determination, and finding speed is fast, accuracy is high, thereby can obtains practical applying.
It is as follows that the present invention measures the method steps of activity of adenosine deaminase:
1), with sample and the reagent mix of mainly forming by adenosine, 2-oxoglutaric acid ester, reduced coenzyme, adenosine triphosphate, phosphoenolpyruvic acid, glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, serum lactic dehydrogenase, make it to take place the reaction of following principle:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
2), detect the end reaction thing in the speed that predominant wavelength 340nm absorbancy descends, calculate the active size of adenosine deaminase.
Common step 2) the end reaction thing is placed under ultraviolet analyser or half, the automatic clinical chemistry analyzer device, detect the speed that predominant wavelength 340nm absorbancy descends, draw the adenosine deaminase measurement result.
The blending ratio of above sample and reagent by volume is 1/10 to 1/250, and the mensuration temperature of above process is controlled at 20 ℃ to 50 ℃ conventional scopes, and the reaction times was controlled at conventional 2-30 minute.
This method is used adenosine deaminase coupling glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, lactic dehydrogenase enzyme reaction continuous monitoring method.Adenosine deaminase enzymolysis adenosine produces ammonia, effect by the coupling glutamate dehydrogenase again, produce L-glutamic acid, generate ADP by Glutamate kinase catalysis and ATP, ADP produces pyruvic acid at last with phosphoenolpyruvic acid again under the effect of pyruvate kinase, effect by the coupling serum lactic dehydrogenase again, reduced coenzyme (absorption peak being arranged at the 340nm place) is oxidized into coenzyme (not having absorption peak at the 340nm place), thereby measured the speed that reduced coenzyme descends in 340nm place absorbancy, by measuring the speed that 340nm place absorbancy descends, can calculate the active size of adenosine deaminase.Advantage of the present invention is that reaction has utilized the reduced coenzyme of two molecules, has also produced the oxidized coenzyme of two molecules, so absorbancy has the duple pace of change, and sensitivity has also just improved two times.
The adenosine deaminase diagnosis reagent kit of realizing the inventive method can be single agent, comprising:
Damping fluid 40--200mmol/l
Adenosine 0.5--50mmol/l
2-oxoglutaric acid ester 1--50mmol/l
Reduced coenzyme 0.15--0.3mmo/l
Adenosine triphosphate 1--10mmol/l
Phosphoenolpyruvic acid 1--10mmol/l
Glutamate dehydrogenase 1000--50000U/l
Glutamate kinase 1000--50000U/l
Pyruvate kinase 500--20000U/l
Lactic dehydrogenase 10 00--50000U/l
Stablizer 10--80% (cumulative volume)
Also above single agent following pair of agent be can be made into, inside and outside source ammonia, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid pollution more helped eliminating:
Reagent I
Damping fluid 40--200mmol/l
2-oxoglutaric acid ester 1--50mmol/l
Reduced coenzyme 0.15--0.3mmo/l
Adenosine triphosphate 1--10mmol/l
Phosphoenolpyruvic acid 1--10mmol/l
Glutamate dehydrogenase 1000--50000U/l
Glutamate kinase 1000--50000U/l
Pyruvate kinase 500--20000U/l
Lactic dehydrogenase 10 00--50000U/l
Stablizer 10--80% (cumulative volume)
Reagent II
Damping fluid 40--200mmol/l
Adenosine 0.5--50mmol/l
Stablizer 10--50mmol/l
The prescription of two agent is not limited only to above-mentioned prescription, the composition of reagent I wherein, 2-oxoglutaric acid ester, reduced coenzyme, adenosine triphosphate, phosphoenolpyruvic acid, glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, serum lactic dehydrogenase etc. can be placed on reagent II.Reagent II composition wherein, adenosine also can be placed on reagent I, so can form multiple formulations, does not describe in detail one by one at this.
Reagent can also be made into following three reagent, not only more help eliminating inside and outside source ammonia, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid pollution, also more help the stable of reagent:
Reagent I
Damping fluid 40--200mmol/l
2-oxoglutaric acid ester 1--50mmol/l
Reduced coenzyme 0.15--0.3mmo/l
Adenosine triphosphate 1--10mmol/l
Phosphoenolpyruvic acid 1--10mmol/l
Stablizer 10--50mmol/l
Reagent II
Damping fluid 40--200mmol/l
Glutamate dehydrogenase 1000--50000U/l
Glutamate kinase 1000--50000U/l
Pyruvate kinase 500--20000U/l
Lactic dehydrogenase 10 00--50000U/l
Stablizer 10--80% (cumulative volume)
Reagent III
Damping fluid 40--200mmol/l
Adenosine 0.5--50mmol/l
Stablizer 10--50mmol/l
Three doses prescription is not limited only to above-mentioned prescription, the composition of reagent I wherein, and 2-oxoglutaric acid ester, reduced coenzyme, adenosine triphosphate, phosphoenolpyruvic acid etc. can be placed among reagent II or the reagent III.Reagent II composition wherein, glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, serum lactic dehydrogenase etc. also can be placed among reagent I or the reagent III, and reagent III composition wherein, adenosine also can be placed among reagent I or the reagent II, so can form multiple formulations, not describe in detail one by one.
The pH scope of buffer reagent can be 6.0~11.0.Buffer reagent can be three (carboxymethyl) aminomethane-hydrochloric acid (Tris-HCl) damping fluid, phosphoric acid salt (Phosphate) damping fluid, trolamine (Triethanolamine) damping fluid, 2-amino-2-methyl-1-propanol (2-Amino-2-methyl-1-propanol) damping fluid, imidazoles (Imidazole) damping fluid or glycylglycine (Glycylglycine) damping fluid etc., but is not limited only to these damping fluids.
Above reduced coenzyme can be reduced form nicotinamide coenzyme or derivatives thereofs such as NADPH, NADH or thio-NADH.
In addition, in order to reduce the cross influence between each reagent composition, the stability of maintenance reagent, so that standing storage, usually add stablizer 10~80% or 10~50mmol/l among reagent I, the reagent II of the reagent I of above single agent, two agent, reagent II or three doses, the reagent III, stablizer can be one or more in ethylene glycol, propylene glycol, glycerine, glycan, polyalcohols, sulfuric acid amine or the salt etc.
Experiment shows, takes all factors into consideration from the accuracy of measurement result and economy two aspects of preparation cost, no matter is single agent, two agent or three doses, and the adenosine deaminase diagnosis reagent kit of the present invention of following system component relation is comparatively desirable:
Damping fluid 80--120mmol/l
Adenosine 2--10mmol/l
2-oxoglutaric acid ester 5--20mmol/l
Reduced coenzyme 0.2--0.3mmo/l
Adenosine triphosphate 2--8mmol/l
Phosphoenolpyruvic acid 2--8mmol/l
Glutamate dehydrogenase 5000--20000U/l
Glutamate kinase 5000--20000U/l
Pyruvate kinase 1000--10000U/l
Serum lactic dehydrogenase 5000--20000U/l
Stablizer 20--50% (cumulative volume)
Because the present invention utilizes Enzymology method, enzyme digestion reaction to have the high characteristics of specificity fully, is not vulnerable to the interference of other materials of inside and outside source.Easy, the easy handling of enzyme process method.The specificity of enzyme digestion reaction impels test result accurate.Enzyme digestion reaction all is to carry out under buffer conditions, does not have environmental pollution problem.The enzyme process method does not need special, extra instrument, and testing cost is cheap.Therefore can guarantee to have higher test accuracy, be more convenient for applying.
In addition, one of striking features of the present invention is the pollution that can eliminate inside and outside source ammonia, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid, the effect of eliminating inside and outside source ammonia, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid occurs in the first half of entire reaction time period, be consumed totally at time second half section contaminated inside and outside source ammonia, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid, and all be the activity that results from adenosine deaminase at the needed ammonia of second half section time test activity of adenosine deaminase, L-glutamic acid, adenosine diphosphate (ADP), pyruvic acid.
Embodiment
The present invention is further illustrated below in conjunction with examples of implementation.
Embodiment one (single agent)
The adenosine deaminase diagnosis reagent kit of present embodiment comprises:
Damping fluid 80mmol/l
Adenosine 2mmol/l
2-oxoglutaric acid ester 5mmol/l
Reduced coenzyme 0.2mmo/l
Adenosine triphosphate 2mmol/l
Phosphoenolpyruvic acid 2mmol/l
Glutamate dehydrogenase 5000U/l
Glutamate kinase 5000U/l
Pyruvate kinase 1000U/l
Serum lactic dehydrogenase 5000U/l
Stablizer 50% (cumulative volume)
On automatic clinical chemistry analyzer, set: 37 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, the volume ratio of tested adenosine deaminase sample and reagent is 1/25, and the Direction of Reaction is negative reaction, 1 minute time of lag, 2 minutes detection times, theoretical k value-4180.
After adding sample and reagent, make it to mix, following reaction take place:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
The end reaction thing is placed under the biochemical analyzer, detect the speed that predominant wavelength 340nm absorbancy descends, thereby calculate the active size of adenosine deaminase.
Present embodiment is used adenosine deaminase coupling glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, lactic dehydrogenase enzyme reaction continuous monitoring method.Adenosine deaminase enzymolysis adenosine produces ammonia, effect by the coupling glutamate dehydrogenase again, produce L-glutamic acid, generate ADP by Glutamate kinase catalysis and ATP, ADP produces pyruvic acid at last with phosphoenolpyruvic acid again under the effect of pyruvate kinase, effect by the coupling serum lactic dehydrogenase again, reduced coenzyme (absorption peak being arranged at the 340nm place) is oxidized into coenzyme (not having absorption peak at the 340nm place), thereby measured the speed that reduced coenzyme descends in 340nm place absorbancy, by measuring the speed that 340nm place absorbancy descends, can calculate the active size of adenosine deaminase.
Embodiment two (two agent)
The adenosine deaminase diagnosing reagent of present embodiment has:
Reagent I
Damping fluid 100mmol/l
2-oxoglutaric acid ester 12mmol/l
Reduced coenzyme 0.25mmo/l
Adenosine triphosphate 5mmol/l
Phosphoenolpyruvic acid 5mmol/l
Glutamate dehydrogenase 12000U/l
Glutamate kinase 12000U/l
Pyruvate kinase 6000U/l
Serum lactic dehydrogenase 12000U/l
Stablizer 50% (cumulative volume)
Reagent II
Damping fluid 100mmol/l
Adenosine 6mmol/l
Stablizer 20mmol/l
When measuring activity of adenosine deaminase, temperature is controlled at 30 ℃, 15 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, the volume ratio of tested adenosine deaminase sample and reagent is 1/25, the Direction of Reaction is negative reaction, 1 minute time of lag, 2 minutes detection times, theoretical k value-4180.
Concrete determination step is:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
The end reaction thing is placed under the biochemical analyzer, detect the speed that predominant wavelength 340nm absorbancy descends, thereby calculate the active size of adenosine deaminase.
The reaction times of each reactions steps was controlled at 15 minutes.
Embodiment three (three doses)
The adenosine deaminase diagnosing reagent of present embodiment is three doses, has:
Reagent I
Damping fluid 120mmol/l
2-oxoglutaric acid ester 20mmol/l
Reduced coenzyme 0.3mmo/l
Adenosine triphosphate 8mmol/l
Phosphoenolpyruvic acid 8mmol/l
Stablizer 20mmol/l
Reagent II
Damping fluid 120mmol/l
Glutamate dehydrogenase 20000U/l
Glutamate kinase 20000U/l
Pyruvate kinase 10000U/l
Serum lactic dehydrogenase 20000U/l
Stablizer 50% (cumulative volume)
Reagent III
Damping fluid 120mmol/l
Adenosine 10mmol/l
Stablizer 20mmol/l
On automatic clinical chemistry analyzer, set: 25 ℃ of temperature, 20 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, the volume ratio of tested adenosine deaminase sample and reagent is 1/25, and the Direction of Reaction is negative reaction, 1 minute time of lag, 2 minutes detection times, theoretical k value-4180.
Concrete determination step is:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
The end reaction thing is placed under the biochemical analyzer, detect the speed that predominant wavelength 340nm absorbancy descends, thereby calculate the active size of adenosine deaminase.
The reaction times of each reactions steps was controlled at 20 minutes.
Embodiment four
The adenosine deaminase diagnosing reagent of present embodiment has:
Reagent I
Damping fluid 100mmol/l
Glutamate dehydrogenase 10000U/l
Glutamate kinase 10000U/l
Pyruvate kinase 6000U/l
Serum lactic dehydrogenase 20000U/l
Stablizer 50% (cumulative volume)
Reagent II
Damping fluid 100mmol/l
Adenosine 3mmol/l
2-oxoglutaric acid ester 8mmol/l
Reduced coenzyme 0.3mmo/l
Adenosine triphosphate 2mmol/l
Phosphoenolpyruvic acid 2mmol/l
Stablizer 50% (cumulative volume)
On Biochemical Analyzer, set: 37 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, the volume ratio of tested adenosine deaminase sample and reagent is 1/25, and the Direction of Reaction is negative reaction, 1 minute time of lag, 2 minutes detection times, theoretical k value-4180.
After adding sample and reagent, make it to mix, following reaction take place:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
The end reaction thing is placed under the biochemical analyzer, detect the speed that predominant wavelength 340nm absorbancy descends, thereby calculate the active size of adenosine deaminase.
In a word, experiment showed, and adopt measuring method of the present invention can draw required measurement result by ultraviolet analyser or half, automatic clinical chemistry analyzer device fully, and highly sensitive, tolerance range good, is not subjected to the pollution of inside and outside source material.

Claims (9)

1. method of measuring activity of adenosine deaminase, step is as follows:
1), with sample and the reagent mix of mainly forming by adenosine, 2-oxoglutaric acid ester, reduced coenzyme, adenosine triphosphate, phosphoenolpyruvic acid, glutamate dehydrogenase, Glutamate kinase, pyruvate kinase, serum lactic dehydrogenase, make it to take place the reaction of following principle:
Adenosine+water Adenosine deaminaseInosine+ammonium ion
Ammonium ion+2-oxoglutaric acid ester+reduced coenzyme Glutamate dehydrogenase
L-glutamic acid+coenzyme+water
Adenosine triphosphate+L-glutamic acid Glutamate kinaseAdenosine diphosphate (ADP)+
L-glutamic acid 5-phosphoric acid
Adenosine diphosphate (ADP)+phosphoenolpyruvic acid Pyruvate kinase
Adenosine triphosphate+pyruvic acid
Pyruvic acid+reduced coenzyme Serum lactic dehydrogenaseLactic acid+coenzyme
2), detect the end reaction thing in the speed that predominant wavelength 340nm absorbancy descends, calculate the active size of adenosine deaminase.
2. according to the method for the described mensuration activity of adenosine deaminase of claim 1, it is characterized in that: described step 2) be, the end reaction thing is placed under ultraviolet analyser or half, the automatic clinical chemistry analyzer, detect the speed that main predominant wavelength 340nm absorbancy descends, calculate the active size of adenosine deaminase.
3, according to the method for claim 1 or 2 described mensuration activity of adenosine deaminase, it is characterized in that: temperature is controlled at 20 ℃ to 50 ℃ scopes, and the reaction times was controlled at 2-30 minute.
4, according to the method for claim 1 or 2 described mensuration activity of adenosine deaminase, it is characterized in that: the ratio control of sample and reagent is 1/10 to 1/250.
5. adenosine deaminase diagnosis reagent kit is grouped into by following one-tenth:
Damping fluid 40--200mmol/l
Adenosine 0.5--50mmol/l
2-oxoglutaric acid ester 1--50mmol/l
Reduced coenzyme 0.15--0.3mmo/l
Adenosine triphosphate 1--10mmol/l
Phosphoenolpyruvic acid 1--10mmol/l
Glutamate dehydrogenase 1000--50000U/l
Glutamate kinase 1000--50000U/l
Pyruvate kinase 500--20000U/l
Lactic dehydrogenase 10 00--50000U/l
Stablizer 10--80% (cumulative volume)
6. according to the described adenosine deaminase diagnosis reagent kit of claim 5, it is characterized in that: described reagent is made into single agent, two agent or three doses.
7. according to claim 5 or 6 described adenosine deaminase diagnosis reagent kits, it is characterized in that: described stablizer is at least a in ethylene glycol, propylene glycol, glycerine, glycan, polyalcohols, ammonium sulfate or the salt.
8. according to claim 5 or 6 described adenosine deaminase diagnosis reagent kits, it is characterized in that: the pH scope of described buffer reagent is 6.0~11.0, and described buffer reagent is a kind of in three (carboxymethyl) aminomethane-hydrochloride buffer, phosphate buffered saline buffer, trolamine damping fluid, 2-amino-2-methyl-1-propanol damping fluid, imidazole buffer or the glycylglycine damping fluid.
9, according to claim 5 or 6 described adenosine deaminase diagnosis reagent kits, it is characterized in that: described reduced coenzyme is a kind of in NADPH, NADH or the thio-NADH reduced form nicotinamide coenzyme or derivatives thereof.
CN 200410065300 2004-11-05 2004-11-05 Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit Pending CN1769482A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410065300 CN1769482A (en) 2004-11-05 2004-11-05 Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410065300 CN1769482A (en) 2004-11-05 2004-11-05 Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit

Publications (1)

Publication Number Publication Date
CN1769482A true CN1769482A (en) 2006-05-10

Family

ID=36751026

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410065300 Pending CN1769482A (en) 2004-11-05 2004-11-05 Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit

Country Status (1)

Country Link
CN (1) CN1769482A (en)

Similar Documents

Publication Publication Date Title
CN1749756A (en) Method for detecting blood ammonia content and blood ammonia diagnostic reagent kit
CN1778963A (en) Determination of blood ammonia content and blood ammonia diagnostic reagent kit
CN1778944A (en) Determination of creatinine content and creatinine diagnostic reagent kit
CN1746316A (en) Determination of adenosine deaminase activity and diagnostic kit of adenosine deaminase
CN1769482A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1769478A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1778947A (en) Creatinine content determination and creatinine diagnostic reagent kit
CN1769477A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1769484A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1769483A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1769479A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1757748A (en) Determination method of creatnine content and creatnine diagnosis reagent box
CN1769475A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1749411A (en) Method for measuring 5'-nucleotidase activity and diagnostic kit of 5'-nucleotidase
CN1757754A (en) Determination method of creatnine content and reagent box for diagnosing creatnine
CN1769470A (en) Adenosine deaminase activity determination method and adenosine deaminase diagnosi kit
CN1757750A (en) Method of determining creatnine content and reagent box for diagnosing creatnine
CN1778946A (en) Determination of blood ammonia content and blood ammonia diagnostic reagent kit
CN1760374A (en) Method for testing activity of 5'-nucleotidase, diagnosis kit for 5'-nucleotidase
CN1757749A (en) Determination method of creatnine content and creatnine oiagnosis reagent box
CN1746317A (en) Determination of adenosine deaminase activity and diagnostic kit of adenosine deaminase
CN1778964A (en) Determination of 5'-nucleotidase activity and its diagnostic reagent kit of 5'-nucleotidase
CN1769480A (en) Creatinine content determination method and creatinine diagnosis kit
CN1749754A (en) Method for detecting blood ammonia content and blood ammonia diagnostic reagent kit
CN1758050A (en) Determination method of creatinine content and reagent box for diagnosing creatinine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication